Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance (in shares) at Dec. 31, 2020		131,365,254
Balance at Dec. 31, 2020	$ 188,896	$ 13	$ 317,084	$ (128,201)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		65,875
Exercise of stock options	16		16
Exercise of warrants (in shares)		233,555
Exercise of Public warrants (in shares)		7,441,020
Exercise of Public warrants	85,555	$ 1	85,554
Settlement of warrant liability upon exercise of warrants	47,162		47,162
Settlement of warrant liability upon call of warrants	591		591
Proceeds from PIC shares recapitalization	75		75
Stock-based compensation expense	442		442
Net (loss) income	61,914			61,914
Balance (in shares) at Mar. 31, 2021		139,105,704
Balance at Mar. 31, 2021	384,651	$ 14	450,924	(66,287)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		29,870
Exercise of stock options	7		7
Issuance of shares in business combination (in shares)		231,002
Issuance of shares in business combination	1,439		1,439
Stock-based compensation expense	754		754
Net (loss) income	(10,469)			(10,469)
Balance (in shares) at Jun. 30, 2021		139,366,576
Balance at Jun. 30, 2021	376,382	$ 14	453,124	(76,756)
Balance (in shares) at Dec. 31, 2021		140,540,671
Balance at Dec. 31, 2021	361,810	$ 14	461,207	(99,411)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		1,312,320
Exercise of stock options	258		258
Issuance of restricted stock (in shares)		2,205
Issuance of shares in business combination (in shares)		100,000
Issuance of shares in business combination	186		186
Stock-based compensation expense	381		381
Net (loss) income	(16,077)			(16,077)
Balance (in shares) at Mar. 31, 2022		141,955,196
Balance at Mar. 31, 2022	346,558	$ 14	462,032	(115,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		440,065
Exercise of stock options	175		175
Issuance of restricted stock (in shares)		97,572
Stock-based compensation expense	1,081		1,081
Net (loss) income	(12,698)			(12,698)
Balance (in shares) at Jun. 30, 2022		142,492,833
Balance at Jun. 30, 2022	$ 335,116	$ 14	$ 463,288	$ (128,186)